Skala / Freedland / Carney Heart Disease

1. Auflage 2005
ISBN: 978-1-61676-313-8
Verlag: Hogrefe Publishing
Format: PDF
Kopierschutz: Wasserzeichen (»Systemvoraussetzungen)

E-Book, Englisch, Band Vol. 2, 90 Seiten

Reihe: Advances in Psychotherapy - Evidence-Based Practice

This volume provides readers with a succinct introduction to behavioral and psychosocial treatment of the two most prevalent cardiac conditions, coronary heart disease and congestive heart failure. It summarizes the latest research on the intricate relationships between these conditions and psychosocial factors such as stress, depression, and anger, as well as behavioral factors such as physical inactivity and non-adherence to cardiac medication regimens. The book provides practical, evidence-based recommendations and clinical tools for assessing and treating these problems – an indispensable treatment manual for professionals who work with cardiac patients.

Autoren/Hrsg.

Skala, Judith A.

Freedland, Kenneth E.

Carney, Robert M.

Fachgebiete

• Sozialwissenschaften Psychologie Psychotherapie / Klinische Psychologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Kardiologie, Angiologie, Phlebologie

Über Autor(innen)

Judith A. Skala, RN, PhD, is a Research Instructor in the Department of Psychiatry at Washington University School of Medicine in St. Louis, MO, and an Instructor in Health Behavior and Health Psychology in the Department of Psychology at Washington University. After 20 years of experience in cardiac and psychiatric nursing, Dr. Skala completed the doctoral program in Clinical Health Psychology at Washington University. She was a Research Coordinator of the landmark ENRICHD clinical trial and has been a cognitive behavior therapist for several other clinical trials of treatments for patients with heart disease.

Kenneth E. Freedland, PhD, is a Professor of Psychiatry and Clinical Health Psychology at Washington University School of Medicine in St. Louis. He is an Associate Editor of Psychosomatic Medicine and is on the editorial board of Health Psychology. His research focuses on the role and treatment of depression and related problems in heart disease. He is a member of the Academy of Behavioral Medicine Research, a Fellow of the Society of Behavioral Medicine, and a Founding Fellow of the Academy of Cognitive Therapy. Dr. Freedland was a CBT supervisor for ENRICHD and has supervised several other clinical trials of CBT for patients with heart disease or other medical illnesses.

Robert M. Carney, PhD, is a Professor of Psychiatry and the Director of the Behavioral Medicine Center at Washington University School of Medicine in St. Louis. Dr. Carney is best known for his pioneering research on the role of depression in coronary heart disease, and he was one of the principal investigators of the ENRICHD clinical trial. He has served on the editorial boards of Annals of Behavioral Medicine, Psychosomatic Medicine, and Journal of Consulting and Clinical Psychology. He has extensive experience as a cognitive behavior therapist and clinical supervisor, and has particular expertise in the treatment of comorbid depression in medically ill patients.